Neurodegenerative diseases: neurobiology, pathogenesis, and therapeutics
Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehens...
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cambridge
Cambridge University Press
2005
|
| Subjects: | |
| Online Access: | DE-12 DE-92 Volltext |
| Summary: | Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehensive survey of each disease and its clinical features. The editors and contributors are among the leading experts in the field internationally. Covering basic science, diagnostic tools and therapeutic approaches, the book focuses on all aspects of neurodegenerative disease, including the normal aging process. The dementias, prion diseases, Parkinson's disease and atypical parkinsonisms, neurodegenerative ataxias, motor neuron diseases, degenerative diseases with chorea, iron and copper disorders, and mitochondrial diseases, are all methodically presented and discussed, with extensive illustrations. In each case the underlying genetics, neuropathological and clinical issues are fully reviewed, making this the most complete as well as the most authoritative reference available to clinicians and neuroscientists |
| Item Description: | Title from publisher's bibliographic system (viewed on 05 Oct 2015) |
| Physical Description: | 1 online resource (xxii, 985 pages) |
| ISBN: | 9780511544873 |
| DOI: | 10.1017/CBO9780511544873 |
Staff View
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043942657 | ||
| 003 | DE-604 | ||
| 005 | 20170227 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161206s2005 xx o|||| 00||| eng d | ||
| 020 | |a 9780511544873 |c Online |9 978-0-511-54487-3 | ||
| 024 | 7 | |a 10.1017/CBO9780511544873 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9780511544873 | ||
| 035 | |a (OCoLC)850409464 | ||
| 035 | |a (DE-599)BVBBV043942657 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-92 | ||
| 082 | 0 | |a 616.8/3 |2 22 | |
| 084 | |a YG 7400 |0 (DE-625)153511:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Neurodegenerative diseases |b neurobiology, pathogenesis, and therapeutics |c [edited by] M. Flint Beal, Anthony E. Lang, Albert C. Ludolph |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2005 | |
| 300 | |a 1 online resource (xxii, 985 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from publisher's bibliographic system (viewed on 05 Oct 2015) | ||
| 505 | 8 | |a Endogenous free radicals and antioxidants in the brain -- Biological oxidants and therapeutic antioxidants -- Mitochondria, metabolic inhibitors and neurodegeneration -- Excitoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases -- Glutamate transporters -- Calcium binding proteins in selective vulnerability of motor neurons -- Apoptosis in neurodegenerative diseases -- Neurotrophic factors -- Protein misfolding and cellular defense mechanisms in neurodegenerative diseases -- Neurodegenerative disease and the repair of oxidatively damaged DNA -- Compounds acting on ion channels -- The role of nitric oxide and PARP in neuronal cell death -- Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis -- The role of inflammation in Alzheimer's disease neuropathology and clinical dementia. From epidemiology to treatment -- Selected genetically engineered models relevant to human neurodegenerative disease | |
| 505 | 8 | |a Friedreich's ataxia and other autosomal recessive ataxias -- Ataxia telangiectasia -- An approach to the patient with motor neuron dysfunction -- The genetics of amyotrophic lateral sclerosis -- Current and potential therapeutics in motor neuron diseases -- The hereditary spastic paraplegias -- Spinal and bulbar muscular atrophy (Kennedy's disease): a sex-limited, polyglutamine repeat expansion disorder -- Spinal muscular atrophies -- Western Pacific ALS/parkinsonism-dementia complex -- Huntington's disease -- Dentatorubral-pallidoluysian atrophy (DRPLA): model for Huntington's disease and other polyglutamine diseases -- Neurocanthocytosis -- Brain iron disorders -- Neurological aspects of Wilson's disease -- Disorders of the mitochondrial respiratory chain | |
| 505 | 8 | |a The neuropathology of Alzheimer's disease in the year 2005 -- Genetics of Alzheimer's disease -- The role of [beta]-amyloid in Alzheimer's disease -- Treatment of Alzheimer's disease -- Dementia with Lewy bodies -- Frontotemporal lobar degeneration -- Frontotemporal dementia with parkinsonism linked to chromosome 17 -- Prion diseases -- Approach to the patient presenting with parkinsonism -- Parkinson's disease -- Neuropathology of Parkinson's disease -- Genetics of parkinsonism -- Pathophysiology: biochemistry of Parkinson's disease -- Current and potential treatments of Parkinson's disease -- Current and potential treatments of Parkonson's disease -- Multiple system atrophy -- Progressive supranuclear palsy -- Corticobasal degeneration -- Approach to the patient with ataxia -- Autosomal dominant cerebellar ataxia | |
| 505 | 8 | |a Toxic animal models -- A genetic outline of the pathways to cell death in Alzheimer's disease, Parkinson's disease, frontal dementias and related disorders -- Neurophysiology of Parkinson's disease, levodopa-induced dyskinesias, dystonia, Huntington's disease and muyoclonus -- Structural and functional magnetic resonance imaging in neurodegenerative diseases -- PET/SPECT -- Magnetic resonance spectroscopy of neurodegenerative illness -- Gene therapy -- Stem cells and cell-based theapy in neurodegenerative disease -- Necessary methodological and stem cell advances for restoration of the dopaminergic system in Parkinson's disease patients -- Clinical aspects of normal aging -- Neuropathology of normal aging in cerebral cortex -- Mild cognitive impairment -- Alzheimer's disease: overview | |
| 520 | |a Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehensive survey of each disease and its clinical features. The editors and contributors are among the leading experts in the field internationally. Covering basic science, diagnostic tools and therapeutic approaches, the book focuses on all aspects of neurodegenerative disease, including the normal aging process. The dementias, prion diseases, Parkinson's disease and atypical parkinsonisms, neurodegenerative ataxias, motor neuron diseases, degenerative diseases with chorea, iron and copper disorders, and mitochondrial diseases, are all methodically presented and discussed, with extensive illustrations. In each case the underlying genetics, neuropathological and clinical issues are fully reviewed, making this the most complete as well as the most authoritative reference available to clinicians and neuroscientists | ||
| 650 | 4 | |a Nervous system / Degeneration | |
| 650 | 4 | |a Nervous system / Diseases / Treatment | |
| 650 | 0 | 7 | |a Nervendegeneration |0 (DE-588)4300182-8 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Nervendegeneration |0 (DE-588)4300182-8 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Beal, M. Flint |d 1950- |0 (DE-588)124005969 |4 edt | |
| 700 | 1 | |a Lang, Anthony E. |4 edt | |
| 700 | 1 | |a Ludolph, Albert C. |d 1953- |0 (DE-588)1081317531 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-81166-8 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/CBO9780511544873 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 912 | |a ZDB-20-CBO | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-029351627 | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511544873 |l DE-12 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511544873 |l DE-92 |p ZDB-20-CBO |q FHN_PDA_CBO |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1817718738915426304 |
|---|---|
| adam_text | |
| any_adam_object | |
| author2 | Beal, M. Flint 1950- Lang, Anthony E. Ludolph, Albert C. 1953- |
| author2_role | edt edt edt |
| author2_variant | m f b mf mfb a e l ae ael a c l ac acl |
| author_GND | (DE-588)124005969 (DE-588)1081317531 |
| author_facet | Beal, M. Flint 1950- Lang, Anthony E. Ludolph, Albert C. 1953- |
| building | Verbundindex |
| bvnumber | BV043942657 |
| classification_rvk | YG 7400 |
| collection | ZDB-20-CBO |
| contents | Endogenous free radicals and antioxidants in the brain -- Biological oxidants and therapeutic antioxidants -- Mitochondria, metabolic inhibitors and neurodegeneration -- Excitoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases -- Glutamate transporters -- Calcium binding proteins in selective vulnerability of motor neurons -- Apoptosis in neurodegenerative diseases -- Neurotrophic factors -- Protein misfolding and cellular defense mechanisms in neurodegenerative diseases -- Neurodegenerative disease and the repair of oxidatively damaged DNA -- Compounds acting on ion channels -- The role of nitric oxide and PARP in neuronal cell death -- Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis -- The role of inflammation in Alzheimer's disease neuropathology and clinical dementia. From epidemiology to treatment -- Selected genetically engineered models relevant to human neurodegenerative disease Friedreich's ataxia and other autosomal recessive ataxias -- Ataxia telangiectasia -- An approach to the patient with motor neuron dysfunction -- The genetics of amyotrophic lateral sclerosis -- Current and potential therapeutics in motor neuron diseases -- The hereditary spastic paraplegias -- Spinal and bulbar muscular atrophy (Kennedy's disease): a sex-limited, polyglutamine repeat expansion disorder -- Spinal muscular atrophies -- Western Pacific ALS/parkinsonism-dementia complex -- Huntington's disease -- Dentatorubral-pallidoluysian atrophy (DRPLA): model for Huntington's disease and other polyglutamine diseases -- Neurocanthocytosis -- Brain iron disorders -- Neurological aspects of Wilson's disease -- Disorders of the mitochondrial respiratory chain The neuropathology of Alzheimer's disease in the year 2005 -- Genetics of Alzheimer's disease -- The role of [beta]-amyloid in Alzheimer's disease -- Treatment of Alzheimer's disease -- Dementia with Lewy bodies -- Frontotemporal lobar degeneration -- Frontotemporal dementia with parkinsonism linked to chromosome 17 -- Prion diseases -- Approach to the patient presenting with parkinsonism -- Parkinson's disease -- Neuropathology of Parkinson's disease -- Genetics of parkinsonism -- Pathophysiology: biochemistry of Parkinson's disease -- Current and potential treatments of Parkinson's disease -- Current and potential treatments of Parkonson's disease -- Multiple system atrophy -- Progressive supranuclear palsy -- Corticobasal degeneration -- Approach to the patient with ataxia -- Autosomal dominant cerebellar ataxia Toxic animal models -- A genetic outline of the pathways to cell death in Alzheimer's disease, Parkinson's disease, frontal dementias and related disorders -- Neurophysiology of Parkinson's disease, levodopa-induced dyskinesias, dystonia, Huntington's disease and muyoclonus -- Structural and functional magnetic resonance imaging in neurodegenerative diseases -- PET/SPECT -- Magnetic resonance spectroscopy of neurodegenerative illness -- Gene therapy -- Stem cells and cell-based theapy in neurodegenerative disease -- Necessary methodological and stem cell advances for restoration of the dopaminergic system in Parkinson's disease patients -- Clinical aspects of normal aging -- Neuropathology of normal aging in cerebral cortex -- Mild cognitive impairment -- Alzheimer's disease: overview |
| ctrlnum | (ZDB-20-CBO)CR9780511544873 (OCoLC)850409464 (DE-599)BVBBV043942657 |
| dewey-full | 616.8/3 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/3 |
| dewey-search | 616.8/3 |
| dewey-sort | 3616.8 13 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1017/CBO9780511544873 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV043942657</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170227</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161206s2005 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511544873</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-511-54487-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/CBO9780511544873</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9780511544873</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)850409464</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043942657</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/3</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 7400</subfield><subfield code="0">(DE-625)153511:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neurodegenerative diseases</subfield><subfield code="b">neurobiology, pathogenesis, and therapeutics</subfield><subfield code="c">[edited by] M. Flint Beal, Anthony E. Lang, Albert C. Ludolph</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xxii, 985 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 05 Oct 2015)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Endogenous free radicals and antioxidants in the brain -- Biological oxidants and therapeutic antioxidants -- Mitochondria, metabolic inhibitors and neurodegeneration -- Excitoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases -- Glutamate transporters -- Calcium binding proteins in selective vulnerability of motor neurons -- Apoptosis in neurodegenerative diseases -- Neurotrophic factors -- Protein misfolding and cellular defense mechanisms in neurodegenerative diseases -- Neurodegenerative disease and the repair of oxidatively damaged DNA -- Compounds acting on ion channels -- The role of nitric oxide and PARP in neuronal cell death -- Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis -- The role of inflammation in Alzheimer's disease neuropathology and clinical dementia. From epidemiology to treatment -- Selected genetically engineered models relevant to human neurodegenerative disease</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Friedreich's ataxia and other autosomal recessive ataxias -- Ataxia telangiectasia -- An approach to the patient with motor neuron dysfunction -- The genetics of amyotrophic lateral sclerosis -- Current and potential therapeutics in motor neuron diseases -- The hereditary spastic paraplegias -- Spinal and bulbar muscular atrophy (Kennedy's disease): a sex-limited, polyglutamine repeat expansion disorder -- Spinal muscular atrophies -- Western Pacific ALS/parkinsonism-dementia complex -- Huntington's disease -- Dentatorubral-pallidoluysian atrophy (DRPLA): model for Huntington's disease and other polyglutamine diseases -- Neurocanthocytosis -- Brain iron disorders -- Neurological aspects of Wilson's disease -- Disorders of the mitochondrial respiratory chain</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The neuropathology of Alzheimer's disease in the year 2005 -- Genetics of Alzheimer's disease -- The role of [beta]-amyloid in Alzheimer's disease -- Treatment of Alzheimer's disease -- Dementia with Lewy bodies -- Frontotemporal lobar degeneration -- Frontotemporal dementia with parkinsonism linked to chromosome 17 -- Prion diseases -- Approach to the patient presenting with parkinsonism -- Parkinson's disease -- Neuropathology of Parkinson's disease -- Genetics of parkinsonism -- Pathophysiology: biochemistry of Parkinson's disease -- Current and potential treatments of Parkinson's disease -- Current and potential treatments of Parkonson's disease -- Multiple system atrophy -- Progressive supranuclear palsy -- Corticobasal degeneration -- Approach to the patient with ataxia -- Autosomal dominant cerebellar ataxia</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Toxic animal models -- A genetic outline of the pathways to cell death in Alzheimer's disease, Parkinson's disease, frontal dementias and related disorders -- Neurophysiology of Parkinson's disease, levodopa-induced dyskinesias, dystonia, Huntington's disease and muyoclonus -- Structural and functional magnetic resonance imaging in neurodegenerative diseases -- PET/SPECT -- Magnetic resonance spectroscopy of neurodegenerative illness -- Gene therapy -- Stem cells and cell-based theapy in neurodegenerative disease -- Necessary methodological and stem cell advances for restoration of the dopaminergic system in Parkinson's disease patients -- Clinical aspects of normal aging -- Neuropathology of normal aging in cerebral cortex -- Mild cognitive impairment -- Alzheimer's disease: overview</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehensive survey of each disease and its clinical features. The editors and contributors are among the leading experts in the field internationally. Covering basic science, diagnostic tools and therapeutic approaches, the book focuses on all aspects of neurodegenerative disease, including the normal aging process. The dementias, prion diseases, Parkinson's disease and atypical parkinsonisms, neurodegenerative ataxias, motor neuron diseases, degenerative diseases with chorea, iron and copper disorders, and mitochondrial diseases, are all methodically presented and discussed, with extensive illustrations. In each case the underlying genetics, neuropathological and clinical issues are fully reviewed, making this the most complete as well as the most authoritative reference available to clinicians and neuroscientists</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nervous system / Degeneration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nervous system / Diseases / Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nervendegeneration</subfield><subfield code="0">(DE-588)4300182-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Nervendegeneration</subfield><subfield code="0">(DE-588)4300182-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beal, M. Flint</subfield><subfield code="d">1950-</subfield><subfield code="0">(DE-588)124005969</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lang, Anthony E.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ludolph, Albert C.</subfield><subfield code="d">1953-</subfield><subfield code="0">(DE-588)1081317531</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-81166-8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/CBO9780511544873</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029351627</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511544873</subfield><subfield code="l">DE-12</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511544873</subfield><subfield code="l">DE-92</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">FHN_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043942657 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-06T19:01:15Z |
| institution | BVB |
| isbn | 9780511544873 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029351627 |
| oclc_num | 850409464 |
| open_access_boolean | |
| owner | DE-12 DE-92 |
| owner_facet | DE-12 DE-92 |
| physical | 1 online resource (xxii, 985 pages) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO FHN_PDA_CBO |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics [edited by] M. Flint Beal, Anthony E. Lang, Albert C. Ludolph Cambridge Cambridge University Press 2005 1 online resource (xxii, 985 pages) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 05 Oct 2015) Endogenous free radicals and antioxidants in the brain -- Biological oxidants and therapeutic antioxidants -- Mitochondria, metabolic inhibitors and neurodegeneration -- Excitoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases -- Glutamate transporters -- Calcium binding proteins in selective vulnerability of motor neurons -- Apoptosis in neurodegenerative diseases -- Neurotrophic factors -- Protein misfolding and cellular defense mechanisms in neurodegenerative diseases -- Neurodegenerative disease and the repair of oxidatively damaged DNA -- Compounds acting on ion channels -- The role of nitric oxide and PARP in neuronal cell death -- Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis -- The role of inflammation in Alzheimer's disease neuropathology and clinical dementia. From epidemiology to treatment -- Selected genetically engineered models relevant to human neurodegenerative disease Friedreich's ataxia and other autosomal recessive ataxias -- Ataxia telangiectasia -- An approach to the patient with motor neuron dysfunction -- The genetics of amyotrophic lateral sclerosis -- Current and potential therapeutics in motor neuron diseases -- The hereditary spastic paraplegias -- Spinal and bulbar muscular atrophy (Kennedy's disease): a sex-limited, polyglutamine repeat expansion disorder -- Spinal muscular atrophies -- Western Pacific ALS/parkinsonism-dementia complex -- Huntington's disease -- Dentatorubral-pallidoluysian atrophy (DRPLA): model for Huntington's disease and other polyglutamine diseases -- Neurocanthocytosis -- Brain iron disorders -- Neurological aspects of Wilson's disease -- Disorders of the mitochondrial respiratory chain The neuropathology of Alzheimer's disease in the year 2005 -- Genetics of Alzheimer's disease -- The role of [beta]-amyloid in Alzheimer's disease -- Treatment of Alzheimer's disease -- Dementia with Lewy bodies -- Frontotemporal lobar degeneration -- Frontotemporal dementia with parkinsonism linked to chromosome 17 -- Prion diseases -- Approach to the patient presenting with parkinsonism -- Parkinson's disease -- Neuropathology of Parkinson's disease -- Genetics of parkinsonism -- Pathophysiology: biochemistry of Parkinson's disease -- Current and potential treatments of Parkinson's disease -- Current and potential treatments of Parkonson's disease -- Multiple system atrophy -- Progressive supranuclear palsy -- Corticobasal degeneration -- Approach to the patient with ataxia -- Autosomal dominant cerebellar ataxia Toxic animal models -- A genetic outline of the pathways to cell death in Alzheimer's disease, Parkinson's disease, frontal dementias and related disorders -- Neurophysiology of Parkinson's disease, levodopa-induced dyskinesias, dystonia, Huntington's disease and muyoclonus -- Structural and functional magnetic resonance imaging in neurodegenerative diseases -- PET/SPECT -- Magnetic resonance spectroscopy of neurodegenerative illness -- Gene therapy -- Stem cells and cell-based theapy in neurodegenerative disease -- Necessary methodological and stem cell advances for restoration of the dopaminergic system in Parkinson's disease patients -- Clinical aspects of normal aging -- Neuropathology of normal aging in cerebral cortex -- Mild cognitive impairment -- Alzheimer's disease: overview Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehensive survey of each disease and its clinical features. The editors and contributors are among the leading experts in the field internationally. Covering basic science, diagnostic tools and therapeutic approaches, the book focuses on all aspects of neurodegenerative disease, including the normal aging process. The dementias, prion diseases, Parkinson's disease and atypical parkinsonisms, neurodegenerative ataxias, motor neuron diseases, degenerative diseases with chorea, iron and copper disorders, and mitochondrial diseases, are all methodically presented and discussed, with extensive illustrations. In each case the underlying genetics, neuropathological and clinical issues are fully reviewed, making this the most complete as well as the most authoritative reference available to clinicians and neuroscientists Nervous system / Degeneration Nervous system / Diseases / Treatment Nervendegeneration (DE-588)4300182-8 gnd rswk-swf Nervendegeneration (DE-588)4300182-8 s 1\p DE-604 Beal, M. Flint 1950- (DE-588)124005969 edt Lang, Anthony E. edt Ludolph, Albert C. 1953- (DE-588)1081317531 edt Erscheint auch als Druckausgabe 978-0-521-81166-8 https://doi.org/10.1017/CBO9780511544873 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics Endogenous free radicals and antioxidants in the brain -- Biological oxidants and therapeutic antioxidants -- Mitochondria, metabolic inhibitors and neurodegeneration -- Excitoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases -- Glutamate transporters -- Calcium binding proteins in selective vulnerability of motor neurons -- Apoptosis in neurodegenerative diseases -- Neurotrophic factors -- Protein misfolding and cellular defense mechanisms in neurodegenerative diseases -- Neurodegenerative disease and the repair of oxidatively damaged DNA -- Compounds acting on ion channels -- The role of nitric oxide and PARP in neuronal cell death -- Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis -- The role of inflammation in Alzheimer's disease neuropathology and clinical dementia. From epidemiology to treatment -- Selected genetically engineered models relevant to human neurodegenerative disease Friedreich's ataxia and other autosomal recessive ataxias -- Ataxia telangiectasia -- An approach to the patient with motor neuron dysfunction -- The genetics of amyotrophic lateral sclerosis -- Current and potential therapeutics in motor neuron diseases -- The hereditary spastic paraplegias -- Spinal and bulbar muscular atrophy (Kennedy's disease): a sex-limited, polyglutamine repeat expansion disorder -- Spinal muscular atrophies -- Western Pacific ALS/parkinsonism-dementia complex -- Huntington's disease -- Dentatorubral-pallidoluysian atrophy (DRPLA): model for Huntington's disease and other polyglutamine diseases -- Neurocanthocytosis -- Brain iron disorders -- Neurological aspects of Wilson's disease -- Disorders of the mitochondrial respiratory chain The neuropathology of Alzheimer's disease in the year 2005 -- Genetics of Alzheimer's disease -- The role of [beta]-amyloid in Alzheimer's disease -- Treatment of Alzheimer's disease -- Dementia with Lewy bodies -- Frontotemporal lobar degeneration -- Frontotemporal dementia with parkinsonism linked to chromosome 17 -- Prion diseases -- Approach to the patient presenting with parkinsonism -- Parkinson's disease -- Neuropathology of Parkinson's disease -- Genetics of parkinsonism -- Pathophysiology: biochemistry of Parkinson's disease -- Current and potential treatments of Parkinson's disease -- Current and potential treatments of Parkonson's disease -- Multiple system atrophy -- Progressive supranuclear palsy -- Corticobasal degeneration -- Approach to the patient with ataxia -- Autosomal dominant cerebellar ataxia Toxic animal models -- A genetic outline of the pathways to cell death in Alzheimer's disease, Parkinson's disease, frontal dementias and related disorders -- Neurophysiology of Parkinson's disease, levodopa-induced dyskinesias, dystonia, Huntington's disease and muyoclonus -- Structural and functional magnetic resonance imaging in neurodegenerative diseases -- PET/SPECT -- Magnetic resonance spectroscopy of neurodegenerative illness -- Gene therapy -- Stem cells and cell-based theapy in neurodegenerative disease -- Necessary methodological and stem cell advances for restoration of the dopaminergic system in Parkinson's disease patients -- Clinical aspects of normal aging -- Neuropathology of normal aging in cerebral cortex -- Mild cognitive impairment -- Alzheimer's disease: overview Nervous system / Degeneration Nervous system / Diseases / Treatment Nervendegeneration (DE-588)4300182-8 gnd |
| subject_GND | (DE-588)4300182-8 |
| title | Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics |
| title_auth | Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics |
| title_exact_search | Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics |
| title_full | Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics [edited by] M. Flint Beal, Anthony E. Lang, Albert C. Ludolph |
| title_fullStr | Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics [edited by] M. Flint Beal, Anthony E. Lang, Albert C. Ludolph |
| title_full_unstemmed | Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics [edited by] M. Flint Beal, Anthony E. Lang, Albert C. Ludolph |
| title_short | Neurodegenerative diseases |
| title_sort | neurodegenerative diseases neurobiology pathogenesis and therapeutics |
| title_sub | neurobiology, pathogenesis, and therapeutics |
| topic | Nervous system / Degeneration Nervous system / Diseases / Treatment Nervendegeneration (DE-588)4300182-8 gnd |
| topic_facet | Nervous system / Degeneration Nervous system / Diseases / Treatment Nervendegeneration |
| url | https://doi.org/10.1017/CBO9780511544873 |
| work_keys_str_mv | AT bealmflint neurodegenerativediseasesneurobiologypathogenesisandtherapeutics AT langanthonye neurodegenerativediseasesneurobiologypathogenesisandtherapeutics AT ludolphalbertc neurodegenerativediseasesneurobiologypathogenesisandtherapeutics |